Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.13000.0000 (0.00%)
At close: 11:07AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1300
Open0.1300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1300 - 0.1300
52 Week Range0.1300 - 0.2700
Volume600
Avg. Volume58
Market Cap1.474B
Beta (5Y Monthly)0.77
PE Ratio (TTM)18.57
EPS (TTM)0.0070
Earnings DateN/A
Forward Dividend & Yield0.00 (1.57%)
Ex-Dividend DateMay 26, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SHPHF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SIHUAN PHARMACEUTICAL HOLD GP L
    Daily Spotlight: Values in Energy, Healthcare, MaterialsInvestors hunting for stocks that reasonably balance long-term growth prospects and current value characteristics might want to look at companies in the Financial Services, Healthcare, and Basic Materials sectors. These are among the groups currently selling for (price/earnings)/(growth+yield) ratios at or below the S&P 500's ratio of 2.2x. To generate PEGY ratios, we use the P/E ratio for each sector based on forward earnings for the numerator. For the denominator, we average the growth rates for the past five years along with two years of forward estimates, in order to achieve a smoother, less-volatile earnings trend. Then we add the current yield to approximate total return. Premium-valued sectors with low growth rates include Consumer Staples and Utilities. Our over-weight sectors include Healthcare, Financial Services, Industrial, Basic Materials and Energy. Our under-weight sectors include Consumer Staples and Communication Services.
    Rating
    Fair Value
    Economic Moat
    17 days agoArgus Research
View more
  • PR Newswire

    Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd.

    Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group:" Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce that Beijing MeiYan KongJian Technology Co., Ltd. ("MeiYan KongJian") under the Group and Bluepha Co., Ltd. ("Bluepha") entered into an agreement on 19 January 2022 for the establishment of joint venture to jointly develop PHA microspheres and biomanufacturing based rege

  • PR Newswire

    Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm

    Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460) is pleased to announce that, its subsidiary Xuanzhu Biopharmaceutical Co., Ltd.( "Xuanzhu Biopharm") has completed a Series B financing of RMB610.5 million on December 31, 2021. This round of financing was led by Sunshine Life Insurance Corporation Limited and joined by Efung Capital, Zhongji Inves

  • PR Newswire

    Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry

    On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the "Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' published an article entitled – 'Medical aesthetic sector needs to achieve best effects and prevent adverse consequences.'

Advertisement
Advertisement